Medical News

RSS

High-fat ketogenic diet safe and effective for controlling childhood seizures

Current and former patients treated with the high-fat ketogenic diet to control multiple, daily and severe seizures can be reassured by the news that not only is the diet effective, but it also appears to have no long-lasting side effects, say scientists at Johns Hopkins Children's Center.

17 Feb 2010

States struggle with insurance cost and coverage in Ohio, Rhode Island and Nebraska

The Columbus Dispatch reports that a health-insurance co-operative founded by Tom Rose, a retired businessman from Marietta, Ohio, "hopes to give people who feel alone in the health-care market that power-in-numbers feeling. ... Benefits Unlimited Inc. started in 2007 and started accepting dues-paying members across the nation last month. ... Annual dues range from $25 for an individual or household to $1,500 for employers or associations with 500 or more people.

17 Feb 2010

Postmenopausal women undergoing combination hormone therapy at increased risk of heart disease: WHI confirms

New analyses from the Women's Health Initiative (WHI) confirm that combination hormone therapy increases the risk of heart disease in healthy postmenopausal women. Researchers report a trend toward an increased risk of heart disease during the first two years of hormone therapy among women who began therapy within 10 years of menopause, and a more marked elevation of risk among women who began hormone therapy more than 10 years after menopause. Analyses indicate that overall a woman's risk of heart disease more than doubles within the first two years of taking combination HT.

17 Feb 2010

Scienta Health signs agreement with Partners HealthCare to provide advanced acute care to its clients

Scienta Health today announced that it has entered into an agreement with Boston-based Partners HealthCare, the leading academic medical network in the U.S. Partners HealthCare includes major teaching hospitals affiliated with Harvard Medical School: the Massachusetts General Hospital, Brigham and Women's Hospital, Dana-Farber Cancer Institute, McLean Hospital, a treatment and research leader in mental illness, chemical dependency and learning disabilities; and Spaulding Rehabilitation Hospital, a top-ranked rehabilitation facility.

17 Feb 2010

Right-ventricular impairment increases risk of death in heart-failure patients

New research from the University of Alabama at Birmingham (UAB) suggests that the ability of right side of the heart to pump blood may be an indication of the risk of death to heart-failure patients whose condition is caused by low function by the left side of their heart.

17 Feb 2010

Investigation: Dangerous caregivers missing from federal database of disciplinary records

News outlets report on health care fraud and legal issues, including missing disciplinary records in a federal database of dangerous caregivers and a new federal bill that would target fake Medicare claims for prescriptions and equipment.

17 Feb 2010

ViewRay earns NorTech Innovation Award for advancements in cancer radiation therapy technology

ViewRay, Inc., a privately held medical device company, has earned a NorTech Innovation Award for its advancements in radiation therapy technology for the treatment of cancer. ViewRay was honored for its unique combination of medical imaging and radiotherapy, which is designed to improve the effectiveness of cancer treatments. Radiation therapy is used to treat nearly two-thirds of today's cancer patients.

17 Feb 2010

Oxytocin hormone improves social behavior in autistic patients

Autism is a disease characterized by difficulties in communicating effectively with other people and developing social relationships. The team led by Angela Sirigu at the Centre de Neuroscience Cognitive (CNRS) has shown that the inhalation of oxytocin, a hormone known to promote mother-infant bonds and social relationships, significantly improved the abilities of autistic patients to interact with other individuals.

17 Feb 2010

Cincinnati-based Secure Content Technologies joins Palisade Systems' VIP Reseller Program

Palisade Systems, the leader In Data Loss Prevention solutions for the small- and medium-sized enterprise, today announces that Cincinnati-based Secure Content Technologies has joined its VIP Reseller Program. As a reseller, Secure Content Technologies will market Palisade Systems PacketSure solution to the small and medium enterprise market seeking a full data loss prevention solution for the various markets including the healthcare, educational and financial sectors.

17 Feb 2010

Generx clinical development opportunities: bioRASI to assist Cardium

Cardium Therapeutics today announced that it has entered into an agreement with bioRASI, an international contract research organization, to assist Cardium in the evaluation of Generx clinical development opportunities within major newly-industrializing markets in Eastern Europe, Asia and Latin America, for patients with chronic coronary artery disease who are either not optimal candidates for or do not have access to costly angioplasty/stenting or cardiac bypass surgery procedures.

17 Feb 2010

TKS4 protein plays significant role in Frank-Ter Haar syndrome

An international team of investigators at Sanford-Burnham Medical Research Institute (Sanford-Burnham, formerly Burnham Institute for Medical Research), Nijmegen Centre for Molecular Life Sciences and other organizations have discovered that TKS4, a protein implicated in cancer metastasis, also plays a significant role in Frank-Ter Haar syndrome (FTHS), a rare fatal disorder.

17 Feb 2010

Rhubarb may have anti-cancer properties, but more research needed

Rhubarb contains natural chemicals called polyphenols that have been shown to kill cancer cells in the lab, or prevent their growth. Baking appears to greatly increase the levels of these chemicals, UK scientists have found, but Cancer Research UK cautioned against reading too much into these results.

17 Feb 2010

Adding daclizumab to standard treatment reduces enlarged brain lesions in patients with relapsing MS

An international team of researchers has found that adding a humanized monoclonal antibody called daclizumab to standard treatment reduces the number of new or enlarged brain lesions in patients with relapsing multiple sclerosis. This new study was published online Feb. 16, 2010, and in the March edition of the Lancet Neurology.

17 Feb 2010

Researchers adopt new technique to inhibit cancer growth

One of the difficulties of fighting cancer is that drugs often hit other non-cancerous cells, causing patients to get sick. But what if researchers could sneak cancer-fighting particles into just the cancer cells?

17 Feb 2010

Quintiles' anatomic pathology services now available in China to help develop effective cancer treatments

Quintiles today announced the availability of anatomic pathology services through its central laboratory in Beijing, China, to help biopharmaceutical companies develop more effective cancer treatments. These services complement assay development, digital pathology and core lab offerings available through the facility to help customers comply with China’s restrictions on tissue import/export.

17 Feb 2010

Certain patients with IBD at increased risk of developing colorectal cancer: AGA's new guidelines

Certain patients with inflammatory bowel disease (IBD), both ulcerative colitis and Crohn's disease of the colon, have an increased risk of developing colorectal cancer compared to individuals without IBD. A number of factors contribute to the increase in risk, which necessitates an individualized and sensible approach to surveillance in patients, according to a new medical position statement and technical review published by the American Gastroenterological Association in its official journal, Gastroenterology.

17 Feb 2010

Osseon Therapeutics completes first Osseoplasty procedures in Europe

Osseon Therapeutics Inc. today announced it has completed its first Osseoplasty™ procedures in Europe. The procedures were performed in Milan, Italy.

17 Feb 2010

Combination of daclizumab and interferon beta significantly reduces MS lesion formation

Biogen Idec and Facet Biotech Corporation today announced the publication of Phase 2 data showing that the addition of daclizumab to interferon beta (IFNβ) led to a significant reduction in the number of new or enlarged multiple sclerosis (MS) lesions when compared to IFNβ alone in patients with active relapsing forms of MS.

17 Feb 2010

Poll says most Americans want to start over on health reform

In a new poll from Zogby International and the University of Texas Health Science Center, more than half of respondents said Congress should start over on health care reforms, The Hill reports.

17 Feb 2010

New research report on orthopedic biomaterials market in the U.S.

According to a new global report series by iData Research (www.idataresearch.net), the leading authority in medical device, dental and pharmaceutical market research, the U.S. market for orthopedic biomaterials grew by 11.5% in 2009 and is estimated to reach almost $6.3 billion by 2016.

17 Feb 2010

Medical News

High-fat ketogenic diet safe and effective for controlling childhood seizures

States struggle with insurance cost and coverage in Ohio, Rhode Island and Nebraska

Postmenopausal women undergoing combination hormone therapy at increased risk of heart disease: WHI confirms

Scienta Health signs agreement with Partners HealthCare to provide advanced acute care to its clients

Right-ventricular impairment increases risk of death in heart-failure patients

Investigation: Dangerous caregivers missing from federal database of disciplinary records

ViewRay earns NorTech Innovation Award for advancements in cancer radiation therapy technology

Oxytocin hormone improves social behavior in autistic patients

Cincinnati-based Secure Content Technologies joins Palisade Systems' VIP Reseller Program

Generx clinical development opportunities: bioRASI to assist Cardium

TKS4 protein plays significant role in Frank-Ter Haar syndrome

Rhubarb may have anti-cancer properties, but more research needed

Adding daclizumab to standard treatment reduces enlarged brain lesions in patients with relapsing MS

Researchers adopt new technique to inhibit cancer growth

Quintiles' anatomic pathology services now available in China to help develop effective cancer treatments

Certain patients with IBD at increased risk of developing colorectal cancer: AGA's new guidelines

Osseon Therapeutics completes first Osseoplasty procedures in Europe

Combination of daclizumab and interferon beta significantly reduces MS lesion formation

Poll says most Americans want to start over on health reform

New research report on orthopedic biomaterials market in the U.S.

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News